ADmit Therapeutics
Focused on the development and commercialization of a novel Alzheimer's disease (AD) early detection technology.
Healthtech
Funding summary
- Total raised
- €200K
- Funding rounds
- 1
Investors in ADmit Therapeutics
Investors on record for ADmit Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like ADmit Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors